Skip to main content
Equibles

FIRST TRUST ADVISORS LP

Position in ANIP — Ani Pharmaceuticals Inc

CIK 1125816 Wheaton, IL
Back to ANIP Full portfolio

Position in ANIP

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$8,101,099
+$430,555 QoQ
Shares Held
97,863
-1.9% QoQ
Ownership
0.426%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 305 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIP Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

FIRST TRUST ADVISORS LP holds $670,557,120 across 30 Drug Manufacturers - Specialty & Generic names. ANIP ranks #11 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
 923,125 $155,583,487
2 UTHR
UNITED THERAPEUTICS Corp
 249,056 $134,946,012
3 ALKS
Alkermes plc.
 2,421,016 $126,861,238
4 ZTS
Zoetis Inc.
 1,435,652 $103,165,952
5 TAK
Takeda Pharmaceutical Co Ltd
 2,114,912 $33,902,039
6 LQDA
Liquidia Corp
 301,432 $24,033,173
7 BCRX
Biocryst Pharmaceuticals Inc
 1,120,469 $11,204,690
8 AMRX
Amneal Pharmaceuticals, Inc.
 614,206 $10,631,905

All Filings in ANIP

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,101,099 97,863
2026-03-31 $7,670,544 99,747
2025-12-31 $6,978,374 88,401
2025-09-30 $6,356,032 69,389
2025-06-30 $5,299,213 81,214
2025-03-31 $2,383,486 35,601
2024-12-31 $1,798,313 32,531
2024-09-30 $2,231,701 37,407
2024-06-30 $3,934,086 61,779